Healthy Japanese
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Japanese 2. Men or women 3. Adults 4. Healthy individuals 5. Individuals whose BMI is < 30 kg/m2 at screening
Exclusion criteria
Exclusion criteria: 1. Individuals who are undergoing medical treatment or have a medical history of malignant tumor, heart failure, or myocardial infarction 2. Individuals who have a pacemaker or an implantable cardioverter defibrillator (ICD) 3. Individuals who are currently undergoing treatment for any of the following chronic diseases: cardiac arrhythmia, liver disorder, chronic kidney disease, cerebrovascular disorder, rheumatic disease, diabetes mellitus, dyslipidemia, hypertension, or any other chronic diseases 4. Individuals who are taking "Foods for Specified Health Uses" or "Foods with Functional Claims" 5. Individuals who are taking or using medicines (including herbal medicines) or supplements, particularly those who regularly take beta-carotene, vitamin A, or multivitamins 6. Individuals who are allergic to medicines or foods related to the test product, particularly wheat, milk, beef, soy, chicken, banana, pork, or apple 7. Individuals who regularly consume vegetables, fruits, yogurt, or other similar foods 8. Individuals who regularly consume alcohol in excess (averaging more than about 20 g of pure alcohol per day) {e.g., 500 mL: a medium bottle of beer or about 1.5 cans of canned chu-hi, 180 mL: 1 go of sake or about 1.5 glasses of wine, 90 mL: half-go with shochu, 60 mL: a glass of whiskey brandy (double)} 9. Individuals who are pregnant, lactating, or planning to become pregnant during this study 10. Individuals who have been enrolled in other clinical studies within the last 28 days before the agreement to participate in this study or plan to participate in another study during this study 11. Individuals who are judged as ineligible to participate in this study by the physician
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Change in blood beta-carotene level from before the intervention to three hours after the intervention | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Measured value of blood beta-carotene level before the intervention and three hours after the intervention | — |
Countries
Japan
Contacts
ORTHOMEDICO Inc. R&D Department